Drugs / AEM-28
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02100839 | Mar → Nov 2014 | familial hypercholesterolemia | LipimetiX Development, LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AEM-28 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02100839 ↗ |
| Known as | Ac-he18a-nh2 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314976 ↗ |
| Route | Intravenous | “Single IV dose for each cohort” NCT02100839 ↗ |